Figure 1.

Comparisons of the proportions of γδ T cell subsets and the ex-vivo expansions of Vδ2⁺ T cells in response to pamidronate between haploHSCT recipients and healthy donors. The proportions and absolute numbers of γδ T cells (A,C) and Vδ2⁺ T cells (B,D) among the total CD3⁺ cells were detected by flow cytometry in recipients 180 days after haploHSCT (n = 35) or in healthy donors (n = 20). Expansion of γδ T cells (E) and Vδ2⁺ T cells (F) from haploHSCT recipients and healthy donors after treatment with pamidronate for 7 and 14 days, respectively. P-values are shown on the graphs, n = 5.